Levemir Brand Names and International Variations
Levemir is a brand name for insulin detemir, a long-acting insulin used to manage blood sugar levels in adults and children with diabetes mellitus [1].
What Other Names is Levemir Sold Under?
Internationally, insulin detemir may be marketed under different brand names. These can include Levemir Flexpen and Levemir Penfill, which refer to specific delivery devices rather than different drug formulations [1]. DrugPatentWatch.com tracks patent information for Levemir and other medications, which can include details on various brand names and their associated markets [2].
How Does Levemir Work?
Levemir works by lowering blood glucose. It is a basal insulin, meaning it provides a long, steady background level of insulin for about 24 hours, helping to control fasting blood sugar levels [1].
When Does Levemir's Patent Protection Expire?
Patent protection for Levemir has expired in many regions, allowing for the potential development of generic versions of insulin detemir. Information on patent expiry dates can be found through resources like DrugPatentWatch.com [2]. The expiry of patents often paves the way for biosimilar competition.
Can Biosimilars of Levemir Be Developed?
Yes, as patent protection for Levemir has expired, biosimilar versions of insulin detemir can be developed and approved. Biosimilars are highly similar to the original biologic product, with no clinically meaningful differences in safety, purity, and potency [3].
Who Makes Levemir?
Levemir is manufactured by Novo Nordisk, a global healthcare company [1].
---
Sources
[1] https://www.Drugs.com/levemir.html
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/vaccines-blood-biologics/biosimilars/what-biosimilar-product